Abstract

Lung adenocarcinoma is one of the most deadly malignancies with a low sur- vival rate.A typical characteristic of this tumor is angiogenesis which stimulates its growth. It is generate following hypoxia that induces activation of the hypoxia-inducible factors (HIFs) including HIF-1α, HIF-1β, HIF-2α, HIF-2β and HIF-3α. Previous studies have demonstrated the expression of these factors in lung adenocarcinomas [1-3]. In the present work we have analyzed their temporal expression profile in lung adenocarcinomas cells A549 by comparing it to that of normal bronchial epithelial cell lines BEAS-2B, during hypoxia with deferoxamine (DFX). This stressor induces a significant, time dependent, reduction of viabilityin both cell lines but more evident in BEAS-2B as shown by MTT analysis. Expression profile of HIFs members was assessed by Western blot analysis. During hypoxia HIF-1α expression increased in both cell lines, with a peak after 6h to 48h and then decreased significantly at 72h following treatment with DFX. HIF-1β levels reached a peak after 72h of treatment in both A549 and BEAS-2B cells, whereas HIF-2βsignificantly increases at 6h in A549 and at 72h in BEAS-2B of hypoxia. HIF-3α expression levels were inversely linked to those of HIF-1α in A549 while this correlation was absent in BEAS-2B. These data were also visualized by immunofluoerescence analysis. The present results have confirmed the involvement of HIFs members in lung cancer.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.